IDEAS home Printed from https://ideas.repec.org/p/ind/igiwpp/2003-006.html
   My bibliography  Save this paper

Interest groups and patent reform in India

Author

Listed:
  • Anita Ramanna

    (Indira Gandhi Institute of Development Research)

Abstract

India's patent reforms represent a shift in India's policy from one of enormous opposition to revising patent laws according to the WTO, to one of compliance with many aspects of TRIPs (Trade Related Intellectual Property Rights) Agreement. Industry and civil society had a strong interest in blocking reforms on IPRs (Intellectual Property Rights), and initially played an important role in preventing reforms of India's patent law. India has recently changed its patent regime, led by important industry groups who revised their positions, and new NGOs that promoted reform. The preferences of actors and their changing interests are important factors in the reform process. Perceived benefits from the new regime partly explain the rise of a pro-reform constituency among industry and NGOs. Yet preference formation is complex and depends on interpretation of strategies by various actors. The Indian pharmaceutical case reflects the imperatives both to forge ahead on patent reform, while protecting the generic market and restricting IPRs. NGOs that emerged to support patent reform also played a role in directing policy towards protecting traditional knowledge. The interests of actors do not always follow predictable paths, and are not fixed. Evaluating the preferences of actors rather than assuming them provides insights into the way policy processes are shaped.

Suggested Citation

  • Anita Ramanna, 2003. "Interest groups and patent reform in India," Indira Gandhi Institute of Development Research, Mumbai Working Papers 2003-006, Indira Gandhi Institute of Development Research, Mumbai, India.
  • Handle: RePEc:ind:igiwpp:2003-006
    as

    Download full text from publisher

    File URL: http://www.igidr.ac.in/pdf/publication/WP-2003-006.pdf
    Download Restriction: no
    ---><---

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Sariola, Salla & Ravindran, Deapica & Kumar, Anand & Jeffery, Roger, 2015. "Big-pharmaceuticalisation: Clinical trials and Contract Research Organisations in India," Social Science & Medicine, Elsevier, vol. 131(C), pages 239-246.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:ind:igiwpp:2003-006. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Shamprasad M. Pujar (email available below). General contact details of provider: https://edirc.repec.org/data/igidrin.html .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.